Dr. Henick is an Assistant Professor of Medicine at Columbia University with clinical and research interests in novel biomarker and drug development for patients with thoracic malignancies.

I am a medical oncologist who specializes in the care of patients with lung cancers, particularly non small-cell lung cancers. I am dedicated to identifying better treatments for people with all stages of disease and to providing compassionate care for patients and their families. My research focuses on developing innovative and effective ways to harness the body’s immune system to fight cancer.

Dr. Rebecca Heist is an Associate Professor of Medicine at Harvard Medical School and thoracic oncologist at Massachusetts General Hospital.

Thoracic Oncologist and clinical trialist at O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham. Focused on all aspects of mechanisms and management of immune related adverse events.

I am a medical oncologist at The Ohio State University Thoracic Oncology Center, who specializes in treating lung cancer patient and developing cutting-edge treatments for these patients. As a faculty member of the OSUCCC Translational Therapeutics Program, Pelotonia Institute for Immuno-Oncology and the OSU Biomedical Sciences Graduate Program, my research focuses on cancer epigenetics, genomics and immunology, and their associated novel biomarker and therapeutic development in lung cancer. My lab studies the determinants for the response and resistance to immunotherapy in lung cancer, and the dynamic immune landscape evolution related to immunotherapy. I serve as an investigator on multiple clinical trials, including novel combined immunotherapy, adaptive T cell therapy and target therapy in lung cancer. I also conduct the translational studies of immunotherapy trials in lung cancer, correlating molecular and immune phenotyping biomarkers with outcomes.

Professor of Medicine, interested in the study and treatment of lung cancer.

Christine Hann is an Associate Professor at the Johns Hopkins University School of Medicine and a member of the Upperaerodigestive Cancer Program at the Sidney Kimmel Comprehensive Cancer Center. Her primary research focus is on developing novel therapeutics for small cell lung cancer.

Dr. Halmos is Chief of Thoracic/Head and Neck Oncology and Director of Clinical Cancer Genomics at Montefiore Medical Center, Professor of Medicine at Albert Einstein College of Medicine

Matthew Gubens, MD, MS, is Associate Professor of Medicine at UCSF, where he practices as a thoracic medical oncologist and serves as Medical Director of thoracic medical oncology and Co-Chair of the Thoracic Oncology Site Committee that oversees the lung cancer clinical trial portfolio. He is particularly active in immunotherapy clinical trials and is the lung cancer liaison to the UCSF Cancer Immunotherapy Program. Dr. Gubens serves on the National Comprehensive Cancer Network panels for non-small cell lung cancer, mesothelioma, and thymic malignancies and on the ASCO Clinical Practice Guidelines Committee. Dr Gubens completed his BA at Yale, his MS at the Harvard School of Public Health, and his MD at Stanford, and trained in internal medicine residency at UCSF and then medical oncology at Stanford.

Jhanelle E. Gray, M.D. is the Department Chair, Program Leader and a Senior Member for Thoracic Oncology at the Moffitt Cancer Center (MCC), co-Leader of the Cancer Center Support Grant Molecular Medicine Program and Professor in the Department of Oncologic Sciences at the University of South Florida Morsani College of Medicine. A renowned Thoracic medical oncologist and clinical scientist, Dr. Gray is actively involved and leads numerous clinical research trials that investigate novel immunotherapeutic and targeted therapy drug combinations for lung cancer which have greatly influenced standard of care treatment. Her research has generated over 80 publications in scholarly, peer-reviewed journals, including original manuscripts and reviews. A leader in NCI cooperative group trials and Chair of the IASLC Membership Committee, Dr. Gray received her undergraduate degree from the University of Florida, Medical Degree from Cornell University Medical College, and completed her internship and residency in Internal Medicine at The New York Presbyterian Hospital - Cornell. Following, she completed her Hematology/Medical Oncology Fellowship at Moffitt Cancer Center. Dr. Gray is actively involved as a member of the MCC Scientific Leadership Council and Clinical Research Action Committee. Globally she is the American Society for Clinical Oncology (ASCO) 2022 Meeting Education Program Chair-elect while also serving as a member of the ASCO Lung Scientific Program Committee, IASLC Women in Thoracic Oncology Working Group and Southwest Oncology Group (SWOG) Lung Working Group.